Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 23:3:2470547019861417.
doi: 10.1177/2470547019861417. eCollection 2019 Jan-Dec.

Neurophysiological Effect of Ketamine on Prefrontal Cortex in Treatment-Resistant Depression: A Combined Transcranial Magnetic Stimulation-Electroencephalography Study

Affiliations

Neurophysiological Effect of Ketamine on Prefrontal Cortex in Treatment-Resistant Depression: A Combined Transcranial Magnetic Stimulation-Electroencephalography Study

Nithya Ramakrishnan et al. Chronic Stress (Thousand Oaks). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Modulation of TEPs and Local Field Power by single pulse TMS administered to DLPFC. (a) The mean SOUND corrected Local Field Power at DLPFC ROI. LMFA-AUC was calculated by summation of LMFA amplitude from 55 to 275ms after TMS pulse. (b) The mean SOUND corrected N100 peak-to-peak amplitude computed between 55 ms and 275ms after TMS pulse. (c) Butterfly plot of TEPs for all electrodes (green) and electrode F3 (red) with most pronounced TEP components labeled. (d) Schematic of the DLPFC ROI shaded in red.
Figure 2.
Figure 2.
a-b: Relationship of cortical excitability measures (LMFA-AUC) and depression scores (a) MADRS and (b)HAM-D. c-d: Pairwise comparison of the session with significance values adjusted by Bonferroni correction for multiple tests for all patients.

Similar articles

Cited by

References

    1. Iadarola ND, Niciu MJ, Richards EM, et al. Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review. Ther Adv Chronic Dis. 2015; 6: 97–114. - PMC - PubMed
    1. Ziemann U, Reis J, Schwenkreis P, et al. TMS and drugs revisited 2014. Clin Neurophysiol. 2015; 126: 1847–1868. - PubMed
    1. Irifune M, Sato T, Kamata Y, et al. Evidence for GABA(A) receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice. Anesth Analg. 2000; 91: 230–236. - PubMed
    1. Wu W, Keller CJ, Rogasch NC, et al. ARTIST: a fully automated artifact rejection algorithm for single-pulse TMS-EEG data. Hum Brain Mapp. 2018; 39: 1607–1625. - PMC - PubMed
    1. Mutanen TP, Metsomaa J, Liljander S, et al. Automatic and robust noise suppression in EEG and MEG: the SOUND algorithm. Neuroimage. 2018; 166: 135–151. - PubMed

LinkOut - more resources